Compare Natera Inc. Common Stock (NTRA) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Open Text Corporation — how do they compare? Natera Inc. Common Stock trades at $393.27 (market cap $57.03B), while Open Text Corporation trades at $24.99 (market cap $6.02B). The key difference: Natera Inc. Common Stock is far larger — about 9.5× Open Text Corporation's market cap, and Open Text Corporation pays a 4.49% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Open Text Corporation for 24 Days on average.
| NTRA | OTEX | |
|---|---|---|
Market Cap | $57.03B | $6.02B |
Volume | 1,131,157 | 1,820,095 |
Sector | Health | Technology |
52-Week High | $425.64 | $39.69 |
52-Week Low | $179.42 | $20.01 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $56.18B | $11.03B |
Dividend Yield | — | 4.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
OpenText (OTEX) trades at $24.95, up 3.18% with strong technical momentum and bullish moving averages. The company demonstrates solid fundamentals with a P/E of 9.67, robust 73.74% gross margins, and consistent earnings beats in recent quarters. Recent debt restructuring activities and strategic AI partnerships with Cohere highlight management's focus on growth optimization and technological advancement.
The outlook remains positive with a consensus price target of $28.30 offering 13% upside potential. Key risks include high debt levels and competitive pressures in the enterprise software sector. Analyst sentiment leans bullish with 42% buy ratings, though the stock faces near-term resistance at the $25 level.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
